Bizarre Patents
An armor with rollers is provided that enables a user to move in all positions by rolling on a hard and smooth surface while constantly varying his bearing points on the ground.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8138148 | GDNF derived peptides The present invention relates to peptide fragments derived from the proteins belonging to the TGFbeta superfamily, pharmaceutical compositions comprising these peptide fragments and uses thereof for treatment of a disease or condition wherein the effects of stimulat... | 03/20/2012 |
| 8071549 | Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells The present invention relates to a compound comprising the third Immunoglobulin (Ig3) module, and/or the fourth Immunoglobulin (Ig4) module, and/or the fifth immunoglobulin (Ig5) module, and/or the first Fibronectin III (Fn3,1) module, and/or the second Fibronectin ... | 12/06/2011 |
| 8043843 | Metabolically engineered lactic acid bacteria and their use Mutants of lactic acid bacteria including Lactococcus lactis which are defective in pyruvate formate-lyase production and/or in their lactate dehydrogenase (Ldh) production and methods of isolating such mutants or variants are provided. The mutants are useful... | 10/25/2011 |
| 8008259 | Neurotrophin-derived peptide sequences The present invention relates to peptide sequences capable of stimulating neuronal cell differentiation, neural cell survival and neuronal plasticity associated with memory and learning. The peptide sequences of the invention are derived from the proteins belonging ... | 08/30/2011 |
| 8003688 | Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract The present invention relates to methods of treating conditions and/or symptoms related to common cold of the upper and/or lower respiratory tract and/or eyes. In particular the invention relates to the methods of treating conditions and/or symptoms related to commo... | 08/23/2011 |
| 7985774 | Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug The present invention relates to the use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug, notably a cardioprotective or hepatoprotective drug. ... | 07/26/2011 |
| 7951906 | Compounds capable of interacting with a cell-surface fibroblast growth factor receptor The present invention relates to a method for modulating the interaction between at least two proteins, wherein at least one of the two proteins is a functional cell-surface receptor and the other protein is the receptor ligand. The invention features a binding site... | 05/31/2011 |
| 7928206 | Pharmaceutical composition comprising a thymidine kinase polynucleotide This invention relates to novel plant thymidine kinases and their use in gene therapy. More specifically the invention provides novel thymidine kinases derived from tomato. In further aspects the invention provides novel polynucleotides encoding the tomato th... | 04/19/2011 |
| 7915201 | Ligational encoding of small molecules The invention relates to a method for synthesising a bifunctional complex comprising an encoded molecule and an identifier polynucleotide identifying the chemical entities having participated in the synthesis of the encoded molecule, said method comprising the steps... | 03/29/2011 |
| 7892583 | Initiation of fermentation The present invention discloses microbial organisms capable of fermenting malic acid to lactic acid having impaired capability of degrading citric acid. These microbial organisms are for example useful in methods of preferentially degrading malic acid over citric ac... | 02/22/2011 |
| 7883884 | Concept for slurry separation and biogas production The present invention concerns an anaerobic digestion of animal manures, energy crops and similar organic substrates. The process is capable of refining nutrients comprised in the digested biomass to fertilizers of commercial quality. The invention also provides a m... | 02/08/2011 |
| 7847058 | Method of modulating cell survival, differentiation and/or synaptic plasticity The present invention relates to a method of modulating differentiation, adhesion and/or survival of the neural cell adhesion molecule (NCAM) presenting cells by providing compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCA... | 12/07/2010 |
| 7869011 | Apparatus and methods for analysis and sorting of particles such as polymer beads The present invention relates to an apparatus for analysing beads and particles, such as polymer beads used e.g. for solid phase synthesis. The apparatus comprises a) a vacuum container comprising at least one planar capture body capable of rotating around a central... | 01/11/2011 |
| 7842294 | Proteins belonging to the Bcl-2 family and fragments thereof, and their use in cancer patients The present invention relates to proteins belonging to the Bcl-2 family and peptides fragments thereof for use in pharmaceutical compositions. The disclosed proteins and peptide fragments are in particularly useful in vaccine compositions for treatment of cancer. Th... | 11/30/2010 |
| 7781207 | In vitro fertilisation The present invention relates to a method and a system for producing a mammalian pre-embryo and a stem cell having a better quality than prior art methods. The system comprises means for obtaining a mammalian oocyte, and means for obtaining a mammalian spermatozoa, ... | 08/24/2010 |
| 7741297 | Immunostimulatory, covalently lipidated oligonucleotides Covalently lipidated oligonucleotides comprising the CpG dinucleotide unit, or an analogue thereof, may be used as immunostimulatory agents to protect against a disease caused by a cancer cell or a pathogen, either alone or in conjunction with immunogens and/or non-... | 06/22/2010 |
| 7727713 | Templated molecules and methods for using such molecules The present invention relates to a method for synthesizing templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of libraries which can be scree... | 06/01/2010 |
| 7704925 | Ligational encoding using building block oligonucleotides The present invention in one aspect relates to a method for synthesizing a bifunctional complex comprising a molecule and an identifier polynucleotide identifying at least some of the chemical entities which have participated in the synthesis of the molecule in acco... | 04/27/2010 |
| 7671086 | Pharmaceutical compositions comprising flavonoids and menthol The present invention relates to use of certain antiviral fragrances for reduction of viruses, in particular vira causing common cold. In one embodiment, the invention relates to pharmaceutical compositions comprising an antiviral fragrance, preferably menthol. Said... | 03/02/2010 |
| 7666639 | Plant deoxyribonucleoside kinase enzymes and their use This invention relates to pharmaceutical compositions comprising plant deoxyribonucleoside kinase enzymes (dNK) capable of phosphorylating nucleoside analogs and to medical use of said dNKs. More specifically the invention relates to the medical use of deoxyribonucl... | 02/23/2010 |
| 7592305 | Use of ghrelin for treating malnutrition in gastrectomized individuals The present invention relates to use of ghrelin or an analogue thereof for the preparation of a medicament for one or more of: treatment and/or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation... | 09/22/2009 |
| 7585890 | Pharmaceutical compositions comprising flavonoids and menthol The present invention relates to use of certain antiviral fragrances for reduction of viruses, in particular vira causing common cold. In one embodiment, the invention relates to pharmaceutical compositions comprising an antiviral fragrance, preferably menthol. Said... | 09/08/2009 |
| 7547541 | In vitro fertilisation The present invention relates to a method and a system for producing a mammalian pre-embryo and a stem cell having a better quality than prior art methods. The system comprises means for obtaining a mammalian oocyte, and means for obtaining a mammalian spermatozoa, ... | 06/16/2009 |
| 6867010 | Enzyme activity screen with direct substrate reloading A method for in vitro selection, from a library of catalyst molecules, of a catalyst molecule of interest having a relatively more efficient specific catalytic activity of interest, as compared to the rest of the catalyst molecules within said library, and wherein s... | 03/15/2005 |
| 7491707 | Synthetic lipid-a-analogs and uses thereof New synthetic Lipid-A analogs based on monosaccharide (1) and disaccharide (2) derivatives were designed and prepared in the present invention. Both structures (1) and (2) incorporate novel lipid structures (3) and (4) that are not found in nature. Also, novel disac... | 02/17/2009 |
| 7465575 | Metabolically engineered lactic acid bacteria and their use Mutants of lactic acid bacteria including Lactococcus lactis which are defective in pyruvate formate-lyase production and/or in their lactate dehydrogenase (Ldh) production and methods of isolating such mutants or variants are provided. The mutants are useful... | 12/16/2008 |
| 7462596 | Pharmaceutical compositions comprising mannose binding lectin The present invention relates to pharmaceutical compositions comprising MBL and/or MBL variants. In particular the invention relates to pharmaceutical compositions comprising at least 200 μg/ml protein containing material, wherein mannan binding lectin (MBL) and/or... | 12/09/2008 |
| 7439224 | Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals The present invention relates to the use of a composition comprising at least one mannan-binding lectin (MBL) subunit, or at least one mannan-binding lectin (MBL) oligomer comprising the at least one mannan-binding lectin (MBL) subunit, in the manufacture of a medic... | 10/21/2008 |
| 7416644 | Method and device for stripping ammonia from liquids The present invention provides a method and a system for stripping volatile compounds such as ammonia from liquids. Part of the ammonia is stripped from the liquid in a system having a shunt through which liquid such as e.g. fermented biomass can be diverted in the ... | 08/26/2008 |
| 7413854 | Method for synthesising templated molecules The invention relates to a method for synthesizing templated molecules attached to the templated which directed the synthesis thereof. The method involves a template, a scaffold functional entity and a functional entity attached to a building block, which, in turn, ... | 08/19/2008 |
| 7402560 | NCAM binding compounds The invention provides novel compounds which are capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM). Additionally, the invention relates to methods for treatment of normal, degenerated and dam... | 07/22/2008 |
| 7393669 | Metabolically engineered micro-organisms having improved galactose uptake A recombinant prototrophic micro-organism such as a yeast is provided which over-expresses the activity of an enzyme catalysing the conversion of glucose-1 phosphate to glucose-6 phosphate in the galactose uptake and metabolism pathway. Suitably the increased enzyme... | 07/01/2008 |
| 7387993 | Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-αinhibitors The present invention relates to the use of subunits and oligomers of mannan-binding lectin (MBL) in prophylactic and/or curative treatment of infections in an individual receiving TNF-inhibiting treatment, in particular TNF-α-inhibiting treatment. The MBL may be a... | 06/17/2008 |
| 7345018 | Method of treating side effects induced by therapeutic agents The invention relates to agents for the prevention of organ damage, in particular of the kidneys and the inner ear, induced by the administration of aminoglycosides. Agents according to the invention are all substances which are megalin and/or cubilin antagonists (i... | 03/18/2008 |
| 7345023 | Treatment of hyperproliferative conditions of body surfaces The present invention relates to pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is... | 03/18/2008 |
| 7309572 | Growth hormone-regulatable liver genes and proteins, and uses thereof Growth homone-regulatable liver genes and proteins are described. These may be used as diagnostic markers of liver pathology. ... | 12/18/2007 |
| 7270989 | Method of producing non-bovine chymosin and use hereof A method of recombinantly producing a non-bovine pre-prochymosin, prochymosin or chymosin derived from ruminant species including deer species, buffalo species, antelope species, giraffe species, ovine species and caprine species; Camelidae species such as Camelu... | 09/18/2007 |
| 7264941 | Surface exposed proteins from The invention relates to the identification of members of a gene family from the human respiratory pathogen Chlamydia pneumoniae, encoding surface exposed membrane proteins of a size of approximately 89-101 kDa, preferably about 89.6-100.3 kDa and about 56.1 ... | 09/04/2007 |
| 7235256 | Method of preventing parturient hypocalcemia in animals and compositions used therein Method of preventing parturient hypocalcemia and milk fever (parturient paresis) in lactating animals comprising administering to the animal during the dry period a compound which reduces absorption of calcium from the drinking water and/or from the ration of said a... | 06/26/2007 |
| 7202207 | Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals The present invention relates to the use of a composition comprising at least one mannan-binding lectin (MBL) subunit, or at least one mannan-binding lectin (MBL) oligomer comprising the at least one mannan-binding lectin (MBL) subunit, in the manufacture of a medic... | 04/10/2007 |
